Clinical Trials Directory

Trials / Completed

CompletedNCT02606240

Low-Flow CO2 Removal for Mild to Moderate ARDS With PRISMALUNG

Extracorporeal CO2 Removal (ECCO2R) With a Renal Replacement Platform (PRISMALUNG) to Enhance Lung Protective Ventilation in Patients With Mild to Moderate Acute Respiratory Distress Syndrome (ARDS)

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Groupe Hospitalier Pitie-Salpetriere · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This pilot observational study will assess changes in pH /PaO2 /PaCO2, Respiratory Rate and device CO2 clearance in the first 24 hours of Extracorporeal CO2 removal (ECCO2R) following tidal volume (Vt), and plateau pressure reduction in patients with mild to moderate ARDS.

Detailed description

Extracorporeal CO2 removal (ECCO2R) with a low-flow CO2 removal device (Prismalung, Gambro-Baxter) integrated on the Prismaflex platform (Gambro-Baxter) allows tidal volume (Vt) and plateau pressure reduction in patients with mild to moderate ARDS. This pilot observational study will assess changes in pH /PaO2 /PaCO2, Respiratory Rate and device CO2 clearance in the first 24 hours of ECCO2R following Vt and plateau pressure reduction in patients with mild to moderate ARDS. Safety variables during treatment will also be analyzed. A series of 20 consecutive patients will be included in this observational study.

Conditions

Interventions

TypeNameDescription
DEVICECO2 removal with PRISMALUNG in ARDSObservational study of patients with mild to moderate Acute Respiratory Distress Syndrome (ARDS) submitted to Extracorporeal CO2 removal (ECCO2R) with the PRISMALUNG device to allow ultraprotective mechanical ventilation with tidal volume reduction (from 6 to 4 ml/kg, predicted body weight) and plateau pressure reduction from 28-30 to 23-25 cmH2O.

Timeline

Start date
2016-03-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2015-11-17
Last updated
2017-08-08

Locations

5 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02606240. Inclusion in this directory is not an endorsement.